Safe and effective induction chemotherapy without cisplatin for squamous cell carcinoma of the head and neck: Impact on complete response rate and survival at five years, following local therapy-Reference-Cited by-同舟云学术

Safe and effective induction chemotherapy without cisplatin for squamous cell carcinoma of the head and neck: Impact on complete response rate and survival at five years, following local therapy

Published:1982 Issue:6 Volume:10 Page:535-548
ISSN:0098-1532
Container-title:Medical and Pediatric Oncology
language:en
Short-container-title:Med. Pediatr. Oncol.

Author:

Price L. A.,Hill Bridget T.

Publisher

Wiley

Subject

Cancer Research,Oncology,Pediatrics, Perinatology and Child Health

Reference25 articles.

1. A kinetically based logical approach to the chemotherapy of head and neck cancer

2. Improved Results in Combination Chemotherapy of Head and Neck Cancer Using a Kinetically-based Approach: A Randomised Study With and Without Adriamycin

3. , (eds): “ Safer Cancer Chemotherapy.” London: Bailliere Tindall, 1981, pp 1–120.

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemotherapy with the “8 in 1” Protocol for Malignant Brain Tumors in Children: A Population-Based Study in Finland;Pediatric Hematology and Oncology;1996-01

2. Evaluation of response to postradiation eight in one chemotherapy in childhood brain tumors;Journal of Neuro-Oncology;1995-10

3. Larynx preservation after initial non-cisplatin containing combination chemotherapy plus radiotherapy, as opposed to surgical intervention with or without radiotherapy in previously untreated advanced head and neck cancer: final analysis after 12 years follow-up;The Journal of Laryngology & Otology;1993-03

4. Impact of Primary Site of Stage III and IV Squamous Cell Carcinomas of the Head and Neck on 7-Year Survival Figures Following Initial Non-Cisplatin-Containing Combination Chemotherapy;Preoperative (Neoadjuvant) Chemotherapy;1993

5. Preirradiation Chemotherapy of Supratentorial Malignant Primary Brain Tumors with Intracarotid cis-Platinum (CDDP) and i.v. BCNU;American Journal of Clinical Oncology;1990-04